Literature DB >> 9266628

The quasispecies of hepatitis C virus and the host immune response.

P Farci1, J Bukh, R H Purcell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9266628     DOI： 10.1007/bf00945022

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  134 in total

1.  Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C.

Authors:  H Toyoda; Y Fukuda; Y Koyama; I Nakano; M Kinoshita; T Hadama; J Takamatsu; T Hayakawa
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

2.  Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis.

Authors:  J J Holland; E Domingo; J C de la Torre; D A Steinhauer
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

Authors:  J I Esteban; J C López-Talavera; J Genescà; P Madoz; L Viladomiu; E Muñiz; C Martin-Vega; M Rosell; H Allende; X Vidal
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

4.  Hypervariable regions in the putative glycoprotein of hepatitis C virus.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; S Ohkoshi; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

5.  Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

Authors:  D B Smith; J Mellor; L M Jarvis; F Davidson; J Kolberg; M Urdea; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

6.  Structure of the 3' terminus of the hepatitis C virus genome.

Authors:  T Tanaka; N Kato; M J Cho; K Sugiyama; K Shimotohno
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Etiology of fulminant hepatic failure: is another virus involved?

Authors:  T L Wright
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

8.  Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.

Authors:  R P González-Peralta; K Qian; J Y She; G L Davis; T Ohno; M Mizokami; J Y Lau
Journal:  J Med Virol       Date:  1996-07       Impact factor: 2.327

9.  Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

Authors:  C Féray; M Gigou; D Samuel; V Paradis; S Mishiro; G Maertens; M Reynés; H Okamoto; H Bismuth; C Bréchot
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

10.  Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo.

Authors:  Y Higashi; S Kakumu; K Yoshioka; T Wakita; M Mizokami; K Ohba; Y Ito; T Ishikawa; M Takayanagi; Y Nagai
Journal:  Virology       Date:  1993-12       Impact factor: 3.616
View more
  25 in total

1.  Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Steven K H Foung; Mansun Law; Jens Bukh
Journal:  Hepatology       Date:  2016-08-09       Impact factor: 17.425

2.  Broadening CD4+ and CD8+ T Cell Responses against Hepatitis C Virus by Vaccination with NS3 Overlapping Peptide Panels in Cross-Priming Liposomes.

Authors:  Jonathan Filskov; Marianne Mikkelsen; Paul R Hansen; Jan P Christensen; Allan R Thomsen; Peter Andersen; Jens Bukh; Else Marie Agger
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

3.  Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators.

Authors:  S H Fang; B L Chiang; M H Wu; H Iba; M Y Lai; P M Yang; D S Chen; L H Hwang
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure.

Authors:  Justin R Bailey; Sarah Laskey; Lisa N Wasilewski; Supriya Munshaw; Liam J Fanning; Elizabeth Kenny-Walsh; Stuart C Ray
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.

Authors:  X Forns; R Thimme; S Govindarajan; S U Emerson; R H Purcell; F V Chisari; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection.

Authors:  A Manzin; L Solforosi; M Debiaggi; F Zara; E Tanzi; L Romanò; A R Zanetti; M Clementi
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 7.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

8.  Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.

Authors:  S E Bassett; D L Thomas; K M Brasky; R E Lanford
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.

Authors:  Sophie Canobio; Cynthia M Guilbert; Myriam Troesch; Johanne Samson; Mireille Lemay; Veronique Anne Pelletier; Anne-Claude Bernard-Bonnin; Rafal Kozielski; Normand Lapointe; Steven R Martin; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies.

Authors:  Lisa N Wasilewski; Ramy El-Diwany; Supriya Munshaw; Anna E Snider; Jillian K Brady; William O Osburn; Stuart C Ray; Justin R Bailey
Journal:  J Virol       Date:  2016-01-27       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.